Amin Mohammed Khan

This inventor holds 9 USPTO granted patents and 2 published patent applications. Top assignees: Gliatech, Inc., The University of Toledo. Active years: 1995-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Amin Mohammed Khan. Retrieved from https://idiyas.com/inventor/amin-mohammed-khan

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 9 (Patent Applications = 2)

% Patents Active = 100.0

Average Co-Inventor Count = 2.6

ph-index = 4

Forward Citations = 26(Granted Patents)

Location History:

Toledo, OH (US) (1995 - 1997)
Solon, OH (US) (1997 - 2000)

Company Filing History:

The University of Toledo

patents

where one patent can have more than one assignee

Years Active: 1995-2000

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6072057 - 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H.sub.3 (2000-06-06),

2. 6008240 - 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives (1999-12-28),

3. 5990317 - 2-(1H-4(5)-imidazoyl) cyclopropyl compounds (1999-11-23),

4. 5663350 - Process for the preparation of intermediates useful for the synthesis of (1997-09-02),

5. 5652258 - 2-(4-imidazoyl) cyclopropyl derivatives (1997-07-29),

6. 5639775 - 4-[4'-piperodinyl or 3'-pirrolidinyl] substituted imidazoles as H.sub.3 (1997-06-17),

7. 5633382 - Histamine H.sub.3 -receptor antagonists and therapeutic uses thereof (1997-05-27),

8. 5486526 - Histamine H.sub.3 -receptor antagonists and therapeutic uses thereof (1996-01-23),

9. 5380858 - Process for the preparation of intermediates useful for the synthesis of (1995-01-10),

Title: Innovations of Amin Mohammed Khan

Introduction

Amin Mohammed Khan is a notable inventor based in Solon, Ohio. He has made significant contributions to the field of chemistry, particularly in the development of compounds with potential therapeutic applications. With a total of nine patents to his name, Khan's work reflects a commitment to advancing scientific knowledge and innovation.

Latest Patents

One of Khan's latest patents includes the invention of 1H-4(5)-cyclo-substituted imidazole derivatives as histamine H3 receptor antagonists. This invention provides compounds that exhibit H3 histamine receptor antagonist activity, characterized by a general formula that includes various substituents. The compounds are designed to have specific properties that may be beneficial in medical applications.

Career Highlights

Throughout his career, Amin Mohammed Khan has worked with esteemed institutions, including the University of Toledo and Gliatech, Inc. His experience in these organizations has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.

Collaborations

Khan has collaborated with notable colleagues such as Graham J. Durant and Clark E. Tedford. These partnerships have enriched his research and expanded the impact of his inventions.

Conclusion

Amin Mohammed Khan's innovative work and numerous patents highlight his significant contributions to the field of chemistry. His dedication to research and development continues to inspire advancements in therapeutic compounds.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents pending: